Northern Trust Corp Revolution Medicines, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 856,623 shares of RVMD stock, worth $42.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

856,623

Previous 1,534,757 44.19%

Holding current value

$42.6 Million

Previous $54.3 Million 41.93%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$31.13 - $41.98 $21.1 Million - $28.5 Million	-678,134 Reduced 44.19%	856,623 $31.5 Million
Q1 2025 May 13, 2025	SELL	$35.36 - $44.42 $188,150 - $236,358	-5,321 Reduced 0.35%	1,534,757 $54.3 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $9.83 Million - $13.9 Million	228,790 Added 17.45%	1,540,078 $67.4 Million
Q3 2024 Nov 13, 2024	BUY	$36.92 - $47.94 $4.85 Million - $6.29 Million	131,272 Added 11.12%	1,311,288 $59.4 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $1.03 Million - $1.39 Million	-34,255 Reduced 2.82%	1,180,016 $45.8 Million
Q1 2024 May 14, 2024	SELL	$26.56 - $33.55 $1.5 Million - $1.9 Million	-56,524 Reduced 4.45%	1,214,271 $39.1 Million
Q4 2023 Feb 13, 2024	BUY	$18.35 - $34.12 $6.2 Million - $11.5 Million	337,670 Added 36.19%	1,270,795 $36.4 Million
Q3 2023 Nov 13, 2023	BUY	$25.17 - $35.05 $388,423 - $540,891	15,432 Added 1.68%	933,125 $25.8 Million
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $2.68 Million - $3.57 Million	132,136 Added 16.82%	917,693 $24.5 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $2.28 Million - $3.31 Million	109,885 Added 16.26%	785,557 $17 Million
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $330,828 - $477,717	18,712 Added 2.85%	675,672 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $310,718 - $462,696	17,796 Added 2.78%	656,960 $13 Million
Q2 2022 Aug 12, 2022	BUY	$14.54 - $27.17 $135,440 - $253,088	9,315 Added 1.48%	639,164 $12.5 Million
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $1.19 Million - $1.82 Million	68,794 Added 12.26%	629,849 $16.1 Million
Q4 2021 Feb 08, 2022	BUY	$24.35 - $33.7 $33,773 - $46,741	1,387 Added 0.25%	561,055 $14.1 Million
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $149,615 - $208,712	-6,247 Reduced 1.1%	559,668 $15.4 Million
Q2 2021 Aug 13, 2021	BUY	$29.0 - $47.44 $2.73 Million - $4.46 Million	94,062 Added 19.93%	565,915 $18 Million
Q1 2021 May 12, 2021	BUY	$37.21 - $54.43 $1.03 Million - $1.5 Million	27,583 Added 6.21%	471,853 $21.6 Million
Q4 2020 Feb 11, 2021	SELL	$30.19 - $45.49 $226,364 - $341,084	-7,498 Reduced 1.66%	444,270 $17.6 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $34.8 $5.77 Million - $8.88 Million	255,285 Added 129.93%	451,768 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $905,688 - $1.81 Million	46,091 Added 30.65%	196,483 $6.2 Million
Q1 2020 May 14, 2020	BUY	$20.0 - $34.08 $3.01 Million - $5.13 Million	150,392 New	150,392 $3.3 Million

Others Institutions Holding RVMD

# of Institutions

334

Shares Held

195M

Call Options Held

908K

Put Options Held

723K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.36B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Revolution Medicines, Inc. Transaction History